We take a deep dive into the challenges facing Sickle Cell patient’s and their ability to access to transformative medicine in our recent insights article, “If Science Can Cure Sickle Cell Disease, Are We Ready to Pay For It?”
Quantile Health is solving the problem of patient access to gene therapies by creating a reimbursement platform that allows payers of all sizes to directly enter into subscription-based access agreements with drug manufacturers